Cell-based therapy improves outcomes in a pig model of heart attacks

In a large-animal model study, researchers have found that heart attack recovery is aided by the injection of heart muscle cell spheroids derived from human-induced pluripotent stem cells (hiPSCs), that overexpress cyclin D2 and are knocked out for human leukocyte antigen classes I and II.

Leave A Comment

Your email address will not be published. Required fields are marked *